Flushing: Clinical Trials

2 trials for Flushing, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2

Follow Flushing: new trials by email Literature Review of Flushing trials Research Report on Flushing

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Efficacy and Tolerance of Two Cosmetic Products in Subjects With Rosacea
SCARCr tester 1, Placebo - Rosacea, Redness
Not applicableCompletedNAOS Argentina S.A.702024-05-162025-02-28
Alternative Options to Minimize Niacin-Induced Flushing
Apple pectin, Aspirin 325 mg, Placebo - Hypercholesterolemia, Flushing
Not applicableCompletedPatrick Moriarty, MD, FACP, FACC1002009-01-012014-06-05

Narrower conditions

Erythema (1)  ·  Hypercholesterolemia (1)  ·  Rosacea (1)  ·  Telangiectasis (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Skin Manifestations (2)  ·  Cardiovascular Diseases (1)  ·  Dyslipidemias (1)  ·  Hyperlipidemias (1)  ·  Lipid Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Vascular Diseases (1)

Interventions

Aspirin (1)

Sponsors

NAOS Argentina S.A. (1)  ·  Patrick Moriarty, MD, FACP, FACC (1)

Countries

Argentina (1)  ·  Brazil (1)  ·  United States (1)

Top investigators

Patrick Moriarty, MD (1)